{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:12:46Z","timestamp":1782025966840,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.antiviral.2007.12.005","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T12:44:37Z","timestamp":1200314677000},"page":"105-113","source":"Crossref","is-referenced-by-count":16,"title":["Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?"],"prefix":"10.1016","volume":"79","author":[{"given":"Dale L.","family":"Barnard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Heiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie-Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.-K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.12.005_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-3542(96)01019-4","article-title":"Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes","volume":"34","author":"Barnard","year":"1997","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.005_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/095632029700800306","article-title":"Acyclic phosphonomethylether nucleoside inhibitors of respiratory viruses","volume":"8","author":"Barnard","year":"1997","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.12.005_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of severe acute respiratory syndrome\u2013associated coronavirus (SARSCoV) by calpain inhibitors and \u00df-d-N4-hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.12.005_bib4","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent anti-picornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.12.005_bib5","series-title":"American Society for Virology Meetings","article-title":"Derivatives of phenothiazine anti-psychotics inhibit severe acute respiratory syndrome\u2013associated coronavirus (SARS-CoV) replication in vitro","author":"Barnard","year":"2005"},{"key":"10.1016\/j.antiviral.2007.12.005_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.005_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00198590","article-title":"A semi-automated NR red based chemosensitivity assay for drug screening","volume":"8","author":"Cavenaugh","year":"1990","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.antiviral.2007.12.005_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1471-4914(03)00135-7","article-title":"Coronavirus in severe acute respiratory syndrome (SARS)","volume":"9","author":"Chan","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.antiviral.2007.12.005_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2005.03.002","article-title":"Development of antiviral therapy for severe acute respiratory syndrome","volume":"66","author":"Cinatl","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.005_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14787210.4.2.291","article-title":"Potential antivirals and antiviral strategies against SARS coronavirus infections","volume":"4","author":"De Clercq","year":"2006","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.antiviral.2007.12.005_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2007.12.005_bib12","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","article-title":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice","volume":"173","author":"Glass","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2007.12.005_bib13","series-title":"Proceedings of the 229th ACS National Meeting","article-title":"Promazine analogues as potential anti SARS-CoV drugs","author":"Hsieh","year":"2005"},{"key":"10.1016\/j.antiviral.2007.12.005_bib14","first-page":"CS71","article-title":"Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics","volume":"9","author":"Kaminska","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.antiviral.2007.12.005_bib15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3201\/eid1010.040445","article-title":"Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China","volume":"10","author":"Liang","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.005_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.47102\/annals-acadmedsg.V35N5p354","article-title":"Laboratory containment of SARS virus","volume":"35","author":"Lim","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.antiviral.2007.12.005_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/ci049809b","article-title":"Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase","volume":"45","author":"Liu","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2007.12.005_bib18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.12.005_bib19","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2007.12.005_bib20","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.12.005_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.antiviral.2007.12.005_bib22","first-page":"119","article-title":"Immunological responses against SARS-coronavirus infection in humans","volume":"1","author":"Xu","year":"2004","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.antiviral.2007.12.005_bib23","first-page":"69","article-title":"Evaluation of anti-tremor drugs in tremor-induced rodents","volume":"155","author":"Yen","year":"1965","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.antiviral.2007.12.005_bib24","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.80.6.2684-2693.2006","article-title":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro","volume":"80","author":"Yen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.12.005_bib25","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bmc.2004.03.035","article-title":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs","volume":"12","author":"Zhang","year":"2004","journal-title":"Bioorg. Med. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207005013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207005013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T20:29:45Z","timestamp":1684182585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207005013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0166354207005013"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.12.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}